Showing results (1321-1330 of 1,436) with videos related to
Sort By:
Pageof 144
Toxicologic Pathology|October 25, 2019
Flavorings-Related Lung Disease: A Brief Review and New Mechanistic DataAnn F Hubbs, Kathleen Kreiss, Kristin J Cummings, et al.British Journal of Haematology|January 30, 2013
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphomaLihua E Budde, Michelle M Zhang, Andrei R Shustov, et al.Blood|May 30, 2008
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2014
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemiaBoglarka Gyurkocza, Jonathan Gutman, Eneida R Nemecek, et al.Circulation Research|May 1, 2026
Chronic Erythrocyte NO Production Accelerates Atherosclerosis by Increasing SMC De Novo LipogenesisBeichen Sun, Rajinikanth Gogiraju, Franziska Greulich, et al.Blood|May 27, 2011
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft modelJohn M Pagel, Aimee L Kenoyer, Tom Bäck, et al.Blood|October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M Pagel, Frederick R Appelbaum, Janet F Eary, et al.Blood Advances|December 7, 2018
Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesisCatharina Wenk, Anne-Kathrin Garz, Sonja Grath, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remissionRaya Mawad, Ted A Gooley, Vicky Sandhu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor ProgressionXiaoming Li, H Michael Shepard, Jessica A Cowell, et al.Pageof 144